PFM
TEVA icon

Parsec Financial Management’s Teva Pharmaceuticals TEVA Stock Holding History

Parsec Financial Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-7,006
Closed -$225K – 202
2017
Q1 		$225K Sell
7,006
-4,764
-40% -$163K 0.02% 187
2016
Q4 		$427K Sell
11,770
-12,875
-52% -$514K 0.04% 150
2016
Q3 		$1.13M Sell
24,645
-1,820
-7% -$95K 0.1% 125
2016
Q2 		$1.33M Sell
26,465
-1,939
-7% -$103K 0.13% 116
2016
Q1 		$1.52M Sell
28,404
-3,673
-11% -$216K 0.15% 115
2015
Q4 		$2.11M Buy
32,077
+3,895
+14% +$241K 0.22% 106
2015
Q3 		$1.59M Sell
28,182
-5,090
-15% -$330K 0.17% 108
2015
Q2 		$1.97M Sell
33,272
-4,788
-13% -$295K 0.2% 98
2015
Q1 		$2.37M Sell
38,060
-26,915
-41% -$1.56M 0.24% 91
2014
Q4 		$3.74M Sell
64,975
-239,999
-79% -$13.4M 0.39% 74
2014
Q3 		$16.4M Sell
304,974
-21,548
-7% -$1.14M 1.79% 15
2014
Q2 		$17.1M Sell
326,522
-152
-0% -$7.77K 1.87% 16
2014
Q1 		$17.3M Buy
326,674
+22,822
+8% +$1.05M 1.95% 15
2013
Q4 		$12.2M Sell
303,852
-16,581
-5% -$653K 1.43% 26
2013
Q3 		$12.1M Buy
320,433
+14,895
+5% +$581K 1.57% 26
2013
Q2 		$12M Buy
+305,538
New +$11.9M 1.62% 25

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Parsec Financial Management's TEVA Position: Q2 2017 in Review

Parsec Financial Management sold out of Teva Pharmaceuticals (TEVA) in Q2 2017, closing a stake of 7,006 shares — an estimated $225K sold.

Parsec Financial Management first reported a position in TEVA in Q2 2013 and held it in 16 quarters. The position peaked at $17.3M in Q1 2014. 648 funds tracked by Wall St. Rank hold TEVA as of Q2 2017.

  • Parsec Financial Management reported no remaining Teva Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
  • Parsec Financial Management sold 7,006 Teva Pharmaceuticals shares in Q2 2017, an estimated $225K.
  • Parsec Financial Management first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 16 quarters.
  • Parsec Financial Management's Teva Pharmaceuticals position peaked at $17.3M in Q1 2014.
  • 648 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2017.

Based on Parsec Financial Management's 13F filing for Q2 2017, filed 28 Jul 2017.